Hosted on MSN15h
Ozempic Shows Potential for Alcohol Addiction in TrialWeekly treatment with low doses of the GLP-1 receptor agonist semaglutide (Ozempic) reduced alcohol consumption and craving ...
A personalized circadian Zeitgeber therapy as an adjunctive treatment for alcohol use disorder patients: results of a pilot ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback